CCl4-induced hepatotoxicity: protective effect of rutin on p53, CYP2E1 and the antioxidative status in rat by Rahmat A Khan et al.
Khan et al. BMC Complementary and Alternative Medicine 2012, 12:178
http://www.biomedcentral.com/1472-6882/12/178RESEARCH ARTICLE Open AccessCCl4-induced hepatotoxicity: protective effect of
rutin on p53, CYP2E1 and the antioxidative status
in rat
Rahmat A Khan1,2*†, Muhammad R Khan2† and Sumaira Sahreen2,3†Abstract
Background: Rutin is a polyphenolic natural flavonoid which possesses antioxidant and anticancer activity. In the
present study the hepatoprotective effect of rutin was evaluated against carbon tetrachloride (CCl4)-induced liver
injuries in rats.
Methods and materials: 24 Sprague–Dawley male rats were equally divided into 4 groups for the assessment of
hepatoprotective potential of rutin. Rats of group I (control) received only vehicles; 1 ml/kg bw of saline (0.85%)
and olive oil (3 ml/kg) and had free access to food and water. Rats of group II, III and IV were treated with CCl4
(30% in olive oil, 3 ml/kg bw) via the intraperitoneal route twice a week for four weeks. The rutin at the doses of 50
and 70 mg/kg were administered intragastrically after 48 h of CCl4 treatment to group III and IV, respectively.
Protective effect of rutin on serum enzyme level, lipid profile, activities of antioxidant enzymes and molecular
markers were calculated in CCl4-induced hepatotoxicity in rat.
Results: Rutin showed significant protection with the depletion of alanine aminotransferase (ALT), aspartate
aminotransferase (AST), alkaline phosphatase (ALP), gamma glutamyl transpeptidase (γ-GT) in serum as was raised
by the induction of CCl4. Concentration of serum triglycerides, total cholesterol and low density lipoproteins was
increased while high-density lipoprotein was decreased with rutin in a dose dependent manner. Activity level of
endogenous liver antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSHpx),
glutathione-S-transferase (GST) and glutathione reductase (GSR) and glutathione (GSH) contents were increased
while lipid peroxidation (TBARS) was decreased dose dependently with rutin. Moreover, increase in DNA
fragmentation and oxo8dG damages while decrease in p53 and CYP 2E1 expression induced with CCl4 was
restored with the treatment of rutin.
Conclusion: From these results, it is suggested that rutin possesses hepatoprotective properties.
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Exposure to toxic chemicals, environmental pollutants
and drugs can cause cellular injuries through metabolic
activation of reactive oxygen species (ROS) [1]. Carbon
tetrachloride (CCl4) has been used extensively to study
hepatotoxicity in animal models by initiating lipid* Correspondence: Rahmatgul_81@yahoo.com
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reproduction in any medium, provided the orperoxidation, thereby causing injuries to kidney, heart,
testis and brain [2-4], in addition to liver pathogenesis
[5]. Liver is particularly susceptible to oxidative stress
due to the direct release of CCl4 metabolites and cyto-
kines, which propagate inflammatory response [6]. CCl4
is one of the xenobiotics that has been reported to in-
duce acute and chronic tissue injuries [7,8] through
bioactivation of the phase I cytochrome P450 system to
form reactive metabolic trichloromethyl radicals (•CCl3)
and peroxy trichloromethyl radicals (•OOCCl3). These
free radicals can covalently bind to macromolecules such
as proteins, lipids and nucleic acids. The double allylicd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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are susceptible to abstraction by free radicals; CCl4 ex-
posure induces an increase in lipoperoxide and free per-
oxide radical concentrations that are highly reactive and
cause injury or necrosis [9,10].
An increase in unsaturated fatty acid lipoperoxide and
free peroxide radical concentrations [11,12], can induce
alterations in the cholesterol profile and decrease in hep-
atic antioxidant enzymes [13], in addition to induction
of oxidative DNA damage including formation of DNA
adducts, genetic mutations, strand breakage and
chromosomal alterations [14]. These free radicals can
cause depletion of CYP2E1 activity [15] and increase in
oxo8dG concentration in tissues of experimental animals
[16]. DNA fragmentation induces p53 gene expression,
blocks cells in the G phase of the cell cycle, and gives
additional time for DNA repair, while severe DNA dam-
age triggers apoptosis [17]. It has been reported that
CCl4 administration increases the silver-stained nucle-
olar organizer region, alters its size, morphology or
spreading in the nucleus, which may be utilized as an in-
dicator of genotoxicity, neoplasia and hyperplasia to
complement other histological procedures [11].
Flavonoids are a large group of polyphenolic com-
pounds that play an important role in detoxification of
free radicals and are markedly found in fruits, vegetables
and medicinal plants [18,19]. Glycosidic flavonoids such
as rutin are much more readily absorbed by humans
than aglycones [20,21]. Rutin possesses antitumor [22],
anti-inflammatory [23] and antimutagenic potential [24],
besides myocardial protection [25] and immunomodu-
lating activities [26]. Therefore, the present study was
designed to investigate the hepatoprotective effects of
rutin against CCl4-induced oxidative stress and its role




Reduced glutathione (GSH), oxidized glutathione (GSSG),
glutathione reductase, gamma-glutamyl p-nitroanilide, gly-
cylglycine, bovine serum albumin (BSA), 1,2-dithio-bis
nitro benzoic acid (DTNB), 1-chloro-2,4-dinitrobenzene
(CDNB), reduced nicotinamide adenine dinucleotide phos-
phate (NADPH), rutin, CCl4, flavine adenine dinucleotide
(FAD), glucose-6-phosphate, Tween-20, 2,6-dichlorophe-
nolindophenol, thiobarbituric acid (TBA), picric acid, so-
dium tungstate, sodium hydroxide, trichloroacetic acid
(TCA) and perchloric acid (PCA) were purchased from
Sigma Chemicals Co. USA.
Animals and treatment
Six week old, 24 Sprague–Dawley male rats (200–210 g)
were provided by National Institute of Health Islamabadand were kept in ordinary cages at room temperature of
25±3°C with a 12 h dark/light cycles. They have free ac-
cess to standard laboratory feed and water, according to
the study protocol approved by Ethical Committee of
Quaid-i-Azam University Islamabad for animal care and
experimentation. To study the hepatoprotective effects
of rutin, rats were equally divided into four groups (six
rats). Animals of group I were treated with 1 ml/kg bw
of saline (0.85%) intragastrically and olive oil (3 ml/kg
bw) intraperitoneally twice a week for four weeks. Rats
of group II, III and IV were treated with CCl4 (30% in
olive oil) at a dose of 3 ml/kg bw intraperitoneally twice
a week for four weeks. Animals of group II received only
CCl4 treatment. However, animals of group III and IV
received rutin at a dose of 50 and 70 mg/kg bw intragas-
trically, respectively, in addition to CCl4 treatment, twice
a week for four weeks.
After 24 h of the last treatment, all the animals were
weighted, sacrificed, collected the blood while liver was
removed, weighted and perfuse in ice-cold saline solu-
tion. Liver samples were treated with liquid nitrogen and
stored at −70 °C for further studies.
Assessment of hepatotoxicity
Liver marker enzymes (alanine aminotransferase (ALT),
aspartate aminotransferase (AST), alkaline phosphatase
(ALP), gamma glutamyl transpeptidase (γ-GT), lipid pro-
file [total cholesterol, low-density lipoprotein (LDL),
high-density lipoprotein (HDL) and triglyceride] were
estimated by using standard AMP diagnostic kits (Stat-
togger Strasse 31b 8045 Graz, Austria). CYP 2E1 (cat no:
E90988Ra, Uscn Life Science Inc.), oxo8dG and p53
(PUMA ELISA Kit cat no: E91909Ra) concentration was
determined with ELISA kit.
Assessment of oxidative stress
For determination of oxidative stress liver tissue was
homogenized in 10 volumes of 100 mmol KH2PO4 buffer
containing 1 mmol EDTA (pH 7.4) and centrifuged at
12,000 × g for 30 min at 4 °C. The supernatant was col-
lected and used for the determination of protein and en-
zymatic studies as described below. Protein concentration
was determined by using crystalline BSA as standard.
CAT and SOD activities are determined with protocol of
[27,28] while phase II metabolizing enzyme, including
glutathione-S-transferase (GST), glutathione reductase
(GSR), glutathione peroxidase (GSH-Px), reduced gluta-
thione (GSH) [29-32] and thiobarbituric acid reactive sub-
stances (TBARS) contents, respectively [33].
DNA damages
Hepatic DNA damages (fragmentation % by DPA assay),
DNA ladder assay [34] and number of NORs per cell
[35] were determined.
Table 1 Effect of Rutin on absolute liver weight, relative liver weight, and % increase in body weight
Treatment % increase in body weight Absolute liver weight (g) Relative liver weight (% to body weight)
Control 35.00±0.87++ 7.00±0.23++ 0.072±0.02++
3 ml/kg CCl4 24.52±0.92** 8.62±.89** 0.086±0.01**
50 mg/kg Rutin+CCl4 30.85±0.96++ 7.21±0.15++ 0.072±0.01++
70 mg/kg Rutin+CCl4 34.09±0.85++ 7.19±0.17++ 0.079±0.03++
Mean ±SE (n=6 number).
** indicate significance from the control group at P<0.01 probability level.
++ indicate significance from the CCl4 group at P<0.01 probability level.
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To determine the treatment effects, one-way analysis of
variance was carried by computer software SPSS 13.0.
Level of significance among the various treatments was
determined by LSD at 0.05% and 0.01% level of
probability.Results
Body weight, liver weight
Treatment of CCl4 caused significant reduction (P<0.01)
in body weight while increased the absolute liver and
relative liver weight comparatively to control group was
significantly (P<0.01) restored with 50 mg/kg bw and 70
mg/kg bw treatment of rutin (Table 1).Lipids profile
Administration of CCl4 increased triglycerides, total
cholesterol, LDL while decreased the HDL as shown in
Table 2. Concentration of HDL was significantly (P<0.01)
increased by rutin whereas concentration of triglycerides,
total cholesterol and LDL was appreciably (P<0.01) aug-
mented to compensate the CCl4-induced toxicity.Genotoxicity studies
Exposure of CCl4 elicited the hepatic DNA damages (%
fragmentation) and number of AgNORs/cell. Percent
serum level of oxo8dG was increased whereas the % ac-
tivity level of p53 and CYP 2E1 was decreased in hepatic
samples of rat. Treatment of rats with 50 mg/kg bw and
70 mg/kg bw of rutin restored the level of these markers
(Table 3). DNA ladder assay showed conformity to the
DNA fragmentation assay (Figure 1).Table 2 Effect of Rutin on Lipids profile
Treatment Triglycerides (mg/dl) Total cholesterol (mg/dl)
Control 7.82±0.45++ 6.13±0.25++
3 ml/kg CCl4 11.13±0.58** 11.22±0.23**
50 mg/kg Rutin+CCl4 8.51±0.44++ 5.72±0.20++
70 mg/kg Rutin+CCl4 7.93±0.90++ 6.94±0.52++
Mean ±SE (n=6 number).
** indicate significance from the control group at P<0.01 probability level.
++ indicate significance from the CCl4 group at P<0.01 probability level.Indices of hepatotoxicity
Administration of CCl4 markedly increased (P<0.01) the
activity of liver serum marker enzymes such as AST,
ALT, ALP and γ-GT as compared with the control
group. Elevations in the secretion of these enzymes were
significantly decreased (P<0.01) by 50 mg/kg bw and 70
mg/kg bw of rutin as compared to the CCl4 group are
shown in Table 4.
Assessment of oxidative stress
CCl4 treatment in rats significantly decreased (P<0.01)
the activity of CAT, SOD, GST, GSH-Px, GSR, GSH
while increased TBARS contents in liver samples. The
increase of lipid peroxidation caused; reduction in the
activities of antioxidant enzymes and glutathione (GSH)
contents were markedly attenuated (P<0.01) by adminis-
tration of 50 mg/kg bw and 70 mg/kg bw of rutin in
intoxicated rats (Table 5).
Discussion
The fields of dietary modification and chemoprevention
show considerable effective approaches against oxidative
stress and are the focus of research these days [36]. Vari-
ous studies have shown that several mutagens and carci-
nogens cause generation of oxygen-free radicals, which
play a major role in the emergence of cancer and other
health disturbances [37,38]. The present study revealed
that CCl4-induction in rats remarkably increased the
level of ALT, AST, ALP and γ-GT. CCl4 causes acute
hepatocyte injuries, altered membrane integrity and as a
result enzymes in hepatocytes leak out [39]. However,
after treatment with rutin, the pathological increases in
ALT, AST, ALP and γ-GT were significantly restored.





Table 3 Effect of Rutin on Genotoxicity studies
Treatment AgNORS (NORs/cell) %DNA fragmentation % oxo8dG % p53 % CYP 2E1
Control 2.02±0.33++ 5.33±1.46++ 4.10±0.53++ 7.13±0.63++ 15.23±1.09++
3 ml/kg CCl4 6.42±0.29** 22.50±3.68** 11.20±0.27** 3.41±0.49** 8.10±0.78**
50 mg/kg Rutin+CCl4 3.32±0.76++ 7.61±1.04++ 6.13±0.26++ 5.15±0.46++ 12.16±1.04++
70 mg/kg Rutin+CCl4 3.11±0.35++ 5.00±1.83++ 5.20±0.85++ 7.10±0.55++ 14.22±1.33++
Mean ±SE (n=6 number).
** indicate significance from the control group at P<0.01 probability level.
++ indicate significance from the CCl4 group at P<0.01 probability level.
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agreement with a previous study [40] that reported the
protective consequence of polyphenolic compounds
against CCl4-induced liver cirrhosis. Importantly, the
increased serum concentrations of triglycerides, total
cholesterol and LDL, and the decreased level of HDL,
were restored to normal values with rutin co-treatment.
This may be explained on the basis that rutin has a
strong ability to chelate multivalent metal ions, espe-
cially zinc, calcium and iron. Indeed, its ability to chelate
minerals has been reported to have some protective
effects, such as decreasing iron mediated free radical for-
mation and lowering serum cholesterol, triglycerides and
lipid peroxides in experimental animals [41]. Similar
findings were reported in another study [42] that investi-
gated the hepatoprotective effects of plant bioactive
compounds against CCl4-induced hepatic injury in rats.
ROS formed during the biotransformation process of
CCl4 are more reactive and toxic than the parental com-
pound. Biotransformation of CCl4 occurs in the endo-
plasmic reticulum and the isoenzyme implicated in this
process is CYP2E1 [43,44]. Our results showed that the
active free radical/intermediate of CCl4 caused a reduc-
tion in CYP2E1, which was markedly restored by rutin
treatment. Our results showed conformity with previous
investigations, which demonstrated that the poly-
phenolic natural product is responsible for its protective,
effects [45,46].Figure 1 Protective effects of rutin on DNA; Lane 1–4 (non
treated control), 5–8 (CCl4 treated rats), 9,10 (CCl4+50 mg/kg b.
w. rutin), 11,12 (CCl4+70 mg/kg b.w. rutin).Results of the present study revealed that exposure of
rats to CCl4 resulted in depletion of antioxidant activities.
In consonance with our results, Szymonik-Lesiuk et al.
[1] reported that CCl4 intoxication leads to changes in
antioxidant enzymes and reactive intermediates involved
in the bioactivation of CCl4 that may truss to those
enzymes to prevent their inactivation. Furthermore, our
results correspond with [11,12], and are in agreement
with an investigation following CCl4 intoxication [47].
Glutathione provides a first line of defense and sca-
venges free radical oxygen species (ROS). The decreased
concentration of GSH in liver may be due to NADPH
reduction or GSH utilization in the exclusion of perox-
ides [48]. GSH-dependent enzymes offer a second line of
protection as they primarily detoxify noxious byproducts
generated by ROS and help to avert dissemination of
free radicals [49]. GSH-Px detoxifies peroxides by react-
ing with GSH and converting it into GSSG, which is
reduced to GSH by GSR [50]. Our study revealed that
CCl4 treatment in rats markedly changed the activity of
antioxidant enzymes, which was reverted by the co-
administration of rutin. Thiobarbituric acid reactive sub-
stances (TBARS), the final metabolites of peroxidized
polyunsaturated fatty acids, are considered as a late bio-
marker of oxidative stress [51]. In our experiments,
major decrease in lipid peroxidation and consequent re-
duction in TBARS were obtained by treatment with
rutin. The increment in lipid peroxidation, as assessed
by the elevated levels of TBARS following CCl4 adminis-
tration, has been well documented [12]. Data of the
present study indicated that lipid peroxidation induced
by oxidative stress caused DNA damage. TBARS react
with the DNA strand to form the M1G adduct, the mu-
tagenic pirimedopurinone adduct of deoxyguanosine
[52]. Administration of rutin markedly reduced the
DNA damage, which is in close agreement with a previ-
ous study [11]. This level of DNA damage decreases the
expression of p53 and blocks cells in the G phase of the
cell cycle, which gives the cells additional time to repair
the DNA damage. However, severe DNA damage may
elicit apoptosis [53]. The data revealed that CCl4-induc-
tion caused marked reduction in p53. This result may be
explained on the basis that CCl4 acts as a tumor pro-
moter through increasing the intracellular concentration





















Control 4.81±0.10++ 22.71±1.18++ 192.12±2.49++ 84.12±5.19++ 127.23±10.52++ 1.23±0.02++ 28.33±1.12++
3 ml/kg CCl4 2.91±0.06** 11.91±0.38** 104.23±2.14** 46.12±3.62** 62.33±9.28** 0.60±.01** 52.17±2.61**
50 mg/kg Rutin+CCl4 4.60±0.16++ 19.52±0.47++ 175.21±2.19++ 70.23±4.31++ 101.13±9.14++ 1.17±0.04++ 31.17±1.74++
70 mg/kg Rutin+CCl4 5.03±0.09++ 21.41±0.62++ 183.32±3.09++ 80.12±6.82++ 121.12±12.24++ 1.18±0.01++ 27.14±1.22++
Mean ±SE (n=6 number).
** indicate significance from the control group at P<0.01 probability level.
++ indicate significance from the CCl4 group at P<0.01 probability level.
Table 4 Effect of Rutin on Indices of hepatotoxicity
Treatment ALT (U/L) AST (U/L) ALP (U/L) γ-GT (nM/min /mg protein)
Control 52.11±2.12++ 76.32±2.74++ 198.10±3.93++ 105.25±2.22++
3 ml/kg CCl4 111.01±3.42** 234.10±4.27** 470.13±6.49** 154.03±3.02**
50 mg/kg Rutin+CCl4 58.01±2.68++ 102.13±4.99++ 227.05±3.89++ 111.03±3.04++
70 mg/kg Rutin+CCl4 56.12±2.05++ 98.61±2.75++ 209.06±3.68++ 107.23±2.01++
Mean ±SE (n=6 number).
** indicate significance from the control group at P<0.01 probability level.
++ indicate significance from the CCl4 group at P<0.01 probability level.
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or may be due to mutation of p53. Our results regarding
p53 are in agreement with previous studies [54,55].
Conclusion
These results demonstrate that administration of rutin
may be useful in the treatment and prevention of hepatic
stress.
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